Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Melinta Therapeutics (United States) | Researchclopedia

Back to institutions

Melinta Therapeutics (United States)

New Havencompany

222

Works

15,542

Citations

64

h-index

Top Research Topics

Antimicrobial Resistance in Staphylococcus Antibiotics Pharmacokinetics and Efficacy Antibiotic Resistance in Bacteria

Top Researchers

Thomas A. Steitz Howard Hughes Medical Institute

515 works50,977 citationsh-index: 120

Recent Research

P-103. Landscape of Post-Marketing Requirements under the Pediatric Research Equity Act for Antibiotics from 2009-2024

Daniel J. Selig,Funmi Aminu,et al.

20260 citations

Pneumonia and Respiratory Infections

Bacterial Identification and Susceptibility Testing

Antibiotic Use and Resistance

Streptococcal Infections and Treatments

RNA and protein synthesis mechanisms

Antifungal resistance and susceptibility

Bacterial Genetics and Biotechnology

Chemical Synthesis and Analysis

Reproductive tract infections research

Bruce G. Haffty Rutgers, The State University of New Jersey

931 works30,528 citationsh-index: 88

Marcus Zervos Henry Ford Health System

447 works23,289 citationsh-index: 82

Eckart Meese Saarland University

470 works21,941 citationsh-index: 75

313 works21,586 citationsh-index: 60

Yi Chen Kunming University of Science and Technology

719 works20,542 citationsh-index: 74

P-1200. Real-World Utilization of Rezafungin in the Outpatient Setting

Nicholas Van Hise,Mark Redell,et al.

20260 citations

The WHO-commissioned systematic reviews on health effects of radiofrequency radiation provide no assurance of safety

Ronald L. Melnick,Joel M. Moskowitz,et al.

20258 citations

Late Breaking Abstract - Efficacy and safety of nalbuphine extended-release in refractory chronic cough: results from the phase 2a RIVER trial

John A. Smith,Kenneth R. Chapman,et al.

20250 citations

Late Breaking Abstract - Responder analysis of nalbuphine extended-release in refractory chronic cough: results from the RIVER phase 2a trial

John A. Smith,Kenneth R. Chapman,et al.

20250 citations

1573P Decoy-resistant IL-18 combination with Bi-specific T cell engager enhances anti-tumor efficacy

Jeffrey N. Lindquist,Kai‐Rong Qin,et al.

20250 citations